TSX · CRON.TO
Cronos Group Inc.
CA$4.65-CA$0.08 (-1.69%)
Cronos Group Inc.’s quoted price sits in the upper half of its reported 52-week range, 6.81% below the high.
Loading market information…
CNQ · HYTN.CN · CAD
Stock price, earnings
Quote as of Oct 30, 2026, 01:30 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
HYTN Innovations Inc.’s quoted price sits in the lower half of its reported 52-week range, 60.61% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow HYTN Innovations Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
HYTN Innovations Inc. is a Canadian firm engaged in the comprehensive development, manufacturing, marketing, distribution, and sale of cannabis products for the recreational adult-use market. The company's future product line is slated to include a diverse array of cannabis-infused sparkling beverages and edible items, offered in various flavor profiles. Its principal operations are based in Vancouver, Canada.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:02 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$4.65-CA$0.08 (-1.69%)
Cronos Group Inc.’s quoted price sits in the upper half of its reported 52-week range, 6.81% below the high.
CA$0.93-CA$0.01 (-1.06%)
Canopy Growth Corporation’s quoted price sits in the lower half of its reported 52-week range, 71.65% below the high.
CA$3.66-CA$0.01 (-0.27%)
Auxly Cannabis Group Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.4% below the high.
CA$0.67-CA$0.02 (-2.9%)
TerrAscend Corp.’s quoted price sits in the lower half of its reported 52-week range, 66.5% below the high.
CA$1.96+CA$0.02 (+1.03%)
Cannara Biotech Inc.’s quoted price sits in the upper half of its reported 52-week range, 17.3% below the high.
CA$1.33-CA$0.04 (-2.92%)
Organigram Global Inc.’s quoted price sits in the lower half of its reported 52-week range, 56.96% below the high.
CA$1.84-CA$0.06 (-3.16%)
Decibel Cannabis Company Inc.’s quoted price sits in the upper half of its reported 52-week range, 15.4% below the high.
CA$0.38CA$0.00 (0.0%)
Rubicon Organics Inc.’s quoted price sits in the lower half of its reported 52-week range, 37.5% below the high.
